Full-Time

Product Support Consultant 2

Posted on 4/18/2024

Model N

Model N

1,001-5,000 employees

Cloud-based revenue management solutions provider

Compensation Overview

$53.1k - $79.7k/yr

+ Bonus + Commission

Junior, Mid

Remote in USA

Category
Data Management
Data Analysis
Data & Analytics
Required Skills
SQL
Java
Salesforce
Oracle
Data Analysis
Requirements
  • Solid communication skills and ability to communicate effectively and professionally with internal and external customers.
  • Intermediate Excel skills including formulas, linked worksheets, formatting, editing, troubleshooting.
  • Strong understanding of relational databases.
  • Ability to work off hours as required and change shifts as 24/7 coverage is needed.
  • Intermediate Microsoft 10, Outlook and Office Suite.
  • Intermediate SQL required.
  • Familiarity with a DBMS like Oracle or SQL Server a plus.
  • Knowledge of Salesforce.com and integration methods a plus.
  • Experience working with Business Objects a plus.
  • Experience working with databases or in data processing environment a plus.
  • Exposure and basic knowledge of a programming language required (Java a plus).
  • Exposure and basic knowledge of a scripting language a plus.
  • Exposure and basic knowledge of XML a plus.
  • Bachelor’s degree or equivalent a plus.
Responsibilities
  • Analyze and implement data formats such as EDI, EDIFACT and Excel for creation and validation of data parsers.
  • Maintain relationships with internal and external clients and assist with identifying and resolving issues and needs.
  • Complete weekly/daily functional tasks, track outputs and create and document processes.
  • Experience monitoring ticket queue and triaging/working on tickets.
  • Collaborate with other members of the Tier 1 and Tier 2 support teams to ensure timely, efficient, and quality service delivery to all customers. Effectively follow established escalation process to Tier 3.
  • Review and understand data flow for all customers.
  • Work with other teams and departments to ensure efficient and optimized data processing and flow.
  • Interface with the Operations, Engineering, QA, CA and Partner Onboarding teams.
  • Manage ad hoc requests from internal and external clients.

Model N provides cloud-based revenue management solutions specifically designed for the high-tech and life sciences industries. Their platform assists clients in maximizing revenue throughout the commercialization process, which includes improving the quote-to-cash process and enhancing relationships with channel partners. Model N's solutions, such as Revenue Cloud for Pharma, Medtech, and High Tech, address the unique pricing and compliance challenges faced by these sectors, helping companies manage global pricing and tender management effectively. Unlike many competitors, Model N operates on a software-as-a-service (SaaS) model, allowing clients to subscribe for ongoing access to their tools and services, which ensures regular updates and support. The company's goal is to help clients bring life-changing products to market more efficiently while navigating regulatory changes, ultimately generating significant savings for their customers.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Mateo, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Model N's GenAI integration enhances data processing and compliance capabilities.
  • The Inflation Reduction Act drives demand for advanced rebate management solutions.
  • Vista Equity Partners' acquisition could accelerate product development and market expansion.

What critics are saying

  • Vista's acquisition may disrupt existing client relationships or alter company focus.
  • New AI capabilities may face adoption challenges if clients aren't ready for advanced tech.
  • Inflation Reduction Act could lead to revenue adjustments for pharmaceutical clients.

What makes Model N unique

  • Model N specializes in revenue management for life sciences and high-tech industries.
  • Their solutions address complex pricing, compliance, and revenue challenges in these sectors.
  • Model N's SaaS model ensures continuous updates and support for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Paid Vacation

Life Insurance

Pet Insurance

Employee Assistance Programs

Mental Health Support

Employee Stock Purchase Plan

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Hit Consultant
Jan 17th, 2025
Recent Digital Health Executive Hires And Promotions: Medidata Expands Team, Carerev, Philips, Eko Health, Others

AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO.Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shield of California appoints Lois Quam as chief executive officer to lead Blue Shield of California, the first woman to serve as CEO in the health plan’s 86-year history. She joined the company as president in 2024.   Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases appoints Troels Jordansen has joined Yaqrit as Chief Executive Officer.OP Solutions names Michael Kallish as Chief Executive Officer, effective immediately.Access TeleCare appoints Dr. Michael Genovese to Chief Medical Officer for Behavioral Health.Enveda appoints Jason Kim as Chief Financial Officer (CFO).Eko Health appoints of Justin Spencer as Chief Financial Officer (CFO). (Pull from site)Qure.ai appoints Jim Mercadante as its new Chief Commercial Officer. (Pull from site)Symplr, appoints Dr

MarketScreener
Jan 6th, 2025
Model N Appoints Bret Connor as Chief Executive Officer

Model N has appointed Bret Connor as Chief Executive Officer.

Hit Consultant
Jan 6th, 2025
Model N Appoints Bret Connor As Ceo To Drive Next Phase Of Growth

Model N Appoints Bret Connor as CEO to Drive Next Phase of Growth. by Healthcare Executive Hires 01/06/2025 Leave a Comment. Bret Connor, CEO at Model NWhat You Should Know: – Model N, a leading provider of revenue optimization and compliance solutions for life sciences and high-tech companies, announced the appointment of Bret Connor as Chief Executive Officer. – Connor brings a wealth of experience in driving customer success and operational excellence, positioning Model N for continued growth and market leadership.  Bret Connor Bio/BackgroundConnor joins Model N from athenahealth, where he served as Chief Operating Officer. During his tenure, he played a key role in the company’s transition to private ownership and spearheaded initiatives focused on client satisfaction and operational excellence. Under his leadership, athenahealth achieved record-high Net Promoter Scores and client retention rates, culminating in a successful recapitalization for $17 billion in 2022. He previously held executive roles at VMware, leading their Professional Services business in the Americas

PharmiWeb
Nov 20th, 2024
Model N Introduces Genai And Intelligent Data Innovations To Market-Leading Revenue Optimization And Compliance Offering

Latest innovations leverage GenAI and enriched data to strengthen global expansion, compliance, and channel sales.SAN MATEO, Calif. – November 20, 2024 – Model N, the leader in revenue optimization and compliance for life sciences and high-tech companies, launched new generative AI (GenAI) and expanded data capabilities to strengthen its core product suite. Integrating GenAI and intelligent data into the company’s Channel Data Management, Formulary Compliance, and Provider Management solutions showcases Model N's strong commitment to delivering continuous innovation and excellence to the world’s most innovative brands in life sciences and high tech.“The opportunity to harness the power of GenAI and intelligent data to help our customers drive revenue growth, strengthen compliance, and achieve market success couldn’t be greater. As we look ahead, continuing to innovate with AI technologies in our product portfolio remains a top priority – empowering our customers to deliver life-changing products,” said Suresh Kannan, Chief Product Officer, Model N.Bolstering Channel Sales by Leveraging GenAIModel N’s new generative AI Catalog Discovery is a part of its Channel Data Management solution that effectively helps high tech companies manage revenue from indirect sources. GenAI Catalog Discovery automates point-of-sale (POS) data processing, converting unstructured product descriptions into structured, actionable data, regardless of language. High-tech manufacturers can use the AI output to identify how their products are used and bundled for consumption

PharmiWeb
May 9th, 2024
Model N Introduces New Rebate Enhancement, As Pharma Companies Prepare For Impact From The Inflation Reduction Act

Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare for Impact from the Inflation Reduction ActNew Medicare Part D inflation rebate enhancement helps pharma manufacturers manage pricing reformsModel N (NYSE: MODN), the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impending IRA regulation and avoid significant revenue loss."The Inflation Reduction Act introduces sweeping changes for drug pricing and Medicare programs, and our goal is to empower customers to stay ahead of these shifts," said Suresh Kannan, Chief Product Officer at Model N. "As our life sciences customers prepare for new reforms and regulatory changes, Model N's latest product innovations address a critical market need by providing the capabilities necessary to calculate and process complex Medicare Part D inflation rebates.”According to Model N’s 2024 State of Revenue Report, pharmaceutical executives are preparing for a significant revenue impact from the IRA. The law aims to lower prescription drug costs for Medicare beneficiaries through provisions allowing the program to negotiate prices for certain high-cost drugs and requiring manufacturers to pay rebates for any price changes higher than the inflation rate. Effective for Medicare Part B and D drugs, manufacturers must calculate inflation penalties based on pricing increases over the designated benchmark periods.Model N's new inflation rebate feature empowers customers to calculate Medicare Part D inflation rebate-per-unit, ensuring compliance with the upcoming IRA regulation set to take effect in 2025. Coupled with Model N's Government Pricing, Payer Management, Provider Management, and Validata solutions, customers gain a unified, end-to-end process to manage pricing strategy, calculate fees, and issue rebate payments in compliance with IRA guidance.The company is committed to ensuring that pharma customers are equipped with the most up-to-date technology to comply with IRA guidance, which will continue to evolve into 2026

INACTIVE